Last edition
News about Industrial talks
Alchem International Appeals to Delhi High Court against Single-Judge Order Banning 'Alchem' Use
The injunction prohibits Alchem from using its name in connection with medicines or medicinal products until further orders. Alchem’s appeal seeks to overturn the interim ban and restore its ability to use its brand amidst the ongoing trademark dispute.
Industrial talks | 17/10/2025 | By Darshana | 382
Aragen Appoints Neeraj Garg as CEO to Bolster Discovery Leadership
In this role at Aragen, Neeraj Garg will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base.
Industrial talks | 16/10/2025 | By Dineshwori | 351
Balaji Amines Under Scrutiny for Producing Pharma-Grade Chemical Without Valid Licence
Indian authorities have accused Balaji Amines of manufacturing pharmaceutical-grade propylene glycol (PG) without possessing the necessary drug manufacturing licence, after certain test batches were reportedly found to be substandard.
Industrial talks | 15/10/2025 | By Darshana | 401
Natco Pharma to Acquire 35.75 Percent Stake in South Africa's Adcock Ingram, Delisting Planned
Natco Pharma has announced its intention to acquire a 35.75 percent equity stake in South Africa’s Adcock Ingram Holdings, in a deal valued at approximately INR 2,000 crore. This transaction is expected to make Natco the second-largest shareholder, while Bidvest will retain a 64.25 percent holding.
Industrial talks | 13/10/2025 | By Darshana | 410
Through a novel public-private partnership, IAVI, Minapharm and ProBioGen will work together to bolster the innovation ecosystem on the continent and enable sustainable access to urgently-needed products.
Industrial talks | 13/10/2025 | By Dineshwori | 179
Kazia Therapeutics Limited, a Sydney-based oncology-focused drug development company, has entered into an exclusive collaboration and in-licensing agreement with QIMR Berghofer to advance a pioneering PD-L1 degrader programme.
Industrial talks | 11/10/2025 | By Darshana | 208
Meril Healthcare Authorises Shukra Pharmaceuticals for Defence Robotic Surgery Projects
Shukra Pharmaceuticals has announced that it has received a letter of authorisation from Meril Healthcare for the “Robotic Assisted Surgery System for Orthopedics” projects at the Directorate General Armed Forces Medical Services (DGAFMS) and INHS Asvini, Colaba, Mumbai (Maharashtra).
Industrial talks | 08/10/2025 | By Dineshwori | 293
Thermo Fisher and DPIIT Launch BioVerse Challenge to Accelerate 500 Biotech Start-Ups in India
Thermo Fisher Scientific, in collaboration with Startup India and the Department for Promotion of Industry and Internal Trade (DPIIT), has launched the BioVerse Challenge — a nationwide initiative aimed at fast-tracking 500 high-potential biotech start-ups across India over the next three years.
Industrial talks | 07/10/2025 | By Darshana | 297
AstraZeneca Partners with Algen Biopharmaceuticals in USD 555 Million Gene Therapy Deal
AstraZeneca has entered into a collaboration and licence agreement valued at up to USD 555 million with United States–based biotechnology company Algen Biopharmaceuticals to develop gene therapies targeting rare diseases.
Industrial talks | 07/10/2025 | By Darshana | 209
AbbVie Cuts 2025 Profit Forecast Following USD 2.7 Billion R&D Charge
The company plans to reduce its adjusted earnings per share guidance to a range of USD 10.38 to USD 10.58, down from its prior forecast of USD 11.88 to USD 12.08.
Industrial talks | 06/10/2025 | By Darshana | 646
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy